Disheartening results for pexelizumab in acute STEMI

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1570, 2007-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pexelizumab: reduced mortality rate after acute MI

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

SY 161-P5 as effective as alteplase in acute STEMI

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

FX 06 fails to FIRE as adjunct treatment for acute STEMI

Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

For patients with acute anterior wall ST-segment elevation myocardial infarction (STEMI), early abciximab prior to angioplasty improves treatment outcomes

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pexelizumab comes up roses in CABG garden

Inpharma, Vol. 1, Iss. 1274, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite